| __timestamp | Viking Therapeutics, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1244910 | 4241601.57 |
| Thursday, January 1, 2015 | 5029636 | 5392385.38 |
| Friday, January 1, 2016 | 4846776 | 7370036.73 |
| Sunday, January 1, 2017 | 5329003 | 14970357 |
| Monday, January 1, 2018 | 7121000 | 31413266 |
| Tuesday, January 1, 2019 | 9128000 | 72279461 |
| Wednesday, January 1, 2020 | 10731000 | 183907682 |
| Friday, January 1, 2021 | 10701000 | 307644000 |
| Saturday, January 1, 2022 | 16121000 | 472132000 |
| Sunday, January 1, 2023 | 37021000 | 709539000 |
In pursuit of knowledge
In the competitive world of biotechnology, operational efficiency is key. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two prominent players: argenx SE and Viking Therapeutics, Inc., from 2014 to 2023. Over this period, argenx SE's SG&A expenses surged by an astounding 16,600%, reflecting its aggressive expansion and strategic investments. In contrast, Viking Therapeutics, Inc. saw a more modest increase of approximately 2,900%, indicating a more conservative growth strategy. By 2023, argenx SE's expenses were nearly 20 times higher than those of Viking Therapeutics, highlighting the divergent paths these companies have taken. This financial snapshot not only underscores the dynamic nature of the biotech industry but also offers insights into how different strategies can shape a company's financial landscape over time.
Merck & Co., Inc. or argenx SE: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Novartis AG and argenx SE
Breaking Down SG&A Expenses: Amgen Inc. vs argenx SE
argenx SE and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
argenx SE or Novavax, Inc.: Who Manages SG&A Costs Better?
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Catalyst Pharmaceuticals, Inc.
Viking Therapeutics, Inc. and Mesoblast Limited: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
Viking Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?